The Committee on Herbal Medicinal Products (HMPC) was established in September 2004, replacing the CPMP Working Party on Herbal Medicinal Products. The Committee was established in accordance with Regulation (EC) No 726/2004 and Directive 2004/24/EC, which introduced a simplified registration procedure for traditional herbal medicinal products in EU Member States.
The HMPC's activities aim at assisting the harmonisation of procedures and provisions concerning herbal medicinal products laid down in EU Member States, and further integrating herbal medicinal products in the European regulatory framework.
As part of these objectives, the HMPC provides EU Member States and European institutions its scientific opinion on questions relating to herbal medicinal products. Other core tasks include the establishment of a draft 'European Union list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products', as well as the establishment of European Union herbal monographs.
The HMPC is composed of scientific experts in the field of herbal medicinal products. It has one member and one alternate member nominated by each of the 28 EU Member States and by each of the EEA-EFTA states Iceland and Norway. The Chair is elected by serving HMPC members.
Up to five additional members (European experts nominated by the Member States or by the Agency) may be co-opted to contribute additional expertise to the HMPC. Currently, the Committee has co-opted members with expertise in clinical pharmacology, experimental/non-clinical pharmacology, toxicology, paediatric medicine and general and family medicine.
The HMPC also has observers from the European Directorate for the Quality of Medicines (EDQM) and Albania, Bosnia and Herzegovina, Kosovo under UNSC Resolution 1244/99, the Former Yugoslav Republic of Macedonia, Montenegro, Serbia and Turkey as part of the EU enlargement programme.
See HMPC members for the list of current members.
The 'HMPC rules of procedure' provide full details of the HMPC's responsibilities, composition and the roles of its members.
How useful is this page?
Average rating:Based on 25 ratings
Add your rating:
- See all ratings
10 ratings3 ratings0 ratings3 ratings9 ratings
- HMPC work plan 2016 (17/02/2016)
- HMPC work programme for 2012-2015 (22/12/2011)
- Policy on scientific publication and representation for European Medicines Agency scientific committees and their members (21/12/2010)
- Policy 9: Appropriate coordination between the Agency's scientific committees (31/10/2008)
European Medicines Agency
30 Churchill Place
London E14 5EU